Monday 26 August 2013

Antipsychotic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Antipsychotic Drugs Market
Antipsychotics are drugs used in the treatment of brain disorders such as schizophrenia, bipolar disorder, and severe depression. According to the New York Times, antipsychotics are one of the largest types of prescribed drugs in the United States with over 3.1 million Americans accounting for a market worth USD 18 billion in 2011 itself. Global estimates suggest that over 1.25% of the global population suffers from psychosis and related disorders. This brings a market of about 7.5 million people suffering from combined disorders of schizophrenia, bipolar disorder, dementia, depression among other rare conditions. 


Several recent studies have suggested instances of drug abuse and over prescription of these drugs in the market, particularly in North America. Clinical studies have shown severe drawbacks and addiction to antipsychotic drugs. A serious side effect observed is tardive dyskinesia which is a potentially irreversible movement disorder. These drugs are prescribed for mild symptoms as well, increasing the market for the drugs tremendously.

Antipsychotics market is expected to increase with increasing incidences of Schizophrenia and a very large market of clinical depression. Certain drugs such as Ablify and Seroquel are the topmost in the segment due to their advantage of reduced risk of side-effects. 2012 has observed the end of the several drug patents and it is expected that generic drugs will compete strongly in the market in the coming years. There is an increasing general call in the medical community for adoption of a stronger control while administering these drugs in the coming years. 

Aripiprazole (marketed as Abilify), Asenapine Maleate (marketed as Saphris), Clozapine (marketed as Clozaril), Iloperidone (marketed as Fanapt), Lurasidone (marketed as Latuda), Olanzapine (marketed as Zyprexa), Olanzapine/Fluoxetine (marketed as Symbyax), Paliperidone (marketed as Invega), Quetiapine (marketed as Seroquel), Risperidone (marketed as Risperdal) and Ziprasidone (marketed as Geodon) are the major atypical antipsychotic drugs marketed today. 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
More reports on Pharmaceuticals market: 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
Posted by at No comments:
Labels: , ,

Uranium Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Uranium Market
Uranium is mostly used in nuclear power plants to generate electricity. The rising demand for electricity and the capacity of nuclear reactors is driving the uranium market. The global uranium market is expected to witness significant growth in next six years. Nearly 75% of uranium supply is through mining activity and it is expected to grow further in the coming years. 


Other secondary sources of uranium include civil stockpiles, recycled uranium, and ex-military weapons-grade uranium. It is expected that there will be a balance between the demand and the supply as the number of new reactors being constructed and old plants retiring is nearly the same. 

In the next six years, it is expected that China, Russia, India, the Middle East, and Europe will expand their use of nuclear energy, creating intense competition for mined uranium. China and Russia are the fastest growing markets and they have already started buying huge stakes in uranium mining operations. 

In 2011, after the incident of Fukushima Daiichi reactor owing to Japan’s tsunami and earthquake, the uranium market might witness slow growth. Shortage of uranium may be experienced in the next few years in spite of the abundance of uranium in the earth’s crust, but it takes many years to build and finance uranium mining operations. 

Some of the major factors driving the market are the growing demand for nuclear energy, the economic advantage associated with uranium production, oil price fluctuations, and increased awareness regarding reducing carbon emissions. The restraint faced by the industry is the high entry barrier because it is a highly capital intensive industry and requires a long time to obtain mining permits. Owing to environmental concerns, obtaining a uranium mining permit is a major challenge.  

The global uranium industry is highly concentrated as very few players are operating in relatively few countries. Russia’s Rosatom and Kazakhstan’s Kazatomprom have entered into a joint venture to dominate the uranium market. Some of the key participants in the market are Cameco Corp., African Energy Resources Ltd, Energy Resources of Australia Ltd, American Uranium Corp. Inc., National Atomic Company Kazatomprom, China National Nuclear Corp., Gulf Mines Ltd., and JOGMEC. 


This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
Posted by at No comments:
Labels: , ,

Sunday 25 August 2013

Multiple Sclerosis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Multiple Sclerosis Drugs Market
Multiple sclerosis (MS) is an inflammation of fatty myelin sheaths around the axons of the brain and spinal cord. MS tends to affect the ability of nerve cells to communicate with each other in the brain and spinal cord. MS affects people with random symptoms based on the location and severity of attack. One event can last for days, weeks or months and can affect any part of the body. Symptoms include imbalance, loss of motor function, spasms, numbness, incontinence, and difficulty in swallowing. 


There is no known cure for the disease currently and the only drugs available in the market are for delaying the progression of the disease. MS is estimated to affect 2.5 million people worldwide with around 5000 new cases developing each year. The National Multiple Sclerosis Society, Multiple Sclerosis Foundation, Multiple Sclerosis Association of America and several others are organizations which are determined to ensure improvement in the lives of affected people to make them more educated and spread awareness of this disease.

Until the last year, the MS drugs market was led primarily by injectables, yet this trend is changing very quickly to give way to oral MS drugs which is expected to grow strongly beginning from 2013. Gilenya and Aubagio are the top current oral drugs in this segment and Biogen’s oral BG-12 and Teva Laquinimod are two other drugs in the pipeline for approval with a significantly higher efficacy to be launched in the next five years. Although oral MS drugs seem to be growing quickly, it is not expected that they would unsettle injectables anytime soon. 

Several fatal side effects have been linked to use of Gilenya among those who have a heart disease and thus shows that there is still a long way to go for oral MS drugs. Top contenders in this segment till now are Copaxone, Avonex, Rebif, Betaseron, and Tysabri. Most of these drugs work actively to control MS relapses. Other treatments such as stem-cell transplantation are currently under investigation. The process includes the injection of stem cells which will replace the affected inflamed and diseased cells, greatly improving patient’s quality of life.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
More reports on Pharmaceutical market: 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
Posted by at No comments:
Labels: , ,

Micro-RNA Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Micro-RNA Market
Micro-RNA is a small non-coding RNA molecule which is a vital component of genetic regulation. Set of micro-RNAs are present in plants and animals functioning in gene expression process. They are involved in the normal functioning of the eukaryotic cells. Biogenesis of micro-RNA is the basis for RNA interference drug discovery and research in therapeutics. 


Micro-RNAs are likely to be involved in biological processes by affecting the gene regulation. Research and development of micro-RNA based therapies are recently being exploited due to the implication of unusually expressed micro-RNA in numerous disorders such as cancer, cardiovascular diseases and HIV infections.

The global micro-RNA market if categorized into:

1. Applications
    • Research
    • Diagnosis
    • Therapeutics
2. Technology
    • Purification
    • Labeling
    • Linear amplification
    • Microarrays
    • qRT-PCR
    • Inhibition
Globally, North America and Europe are the leading regions with booming micro-RNA market. Emerging economies of Asia such as India, Japan, China and Singapore as well as the Middle East and Latin American countries are also expected to show soaring progress in the growth of micro-RNA market.

One of the key factors driving the global micro-RNA market is provision of large scale funding by public and private sectors. Other factors responsible for the growth of this market are growing interest of pharmaceutical and biotechnological companies in conducting research on micro-RNAs and identification of micro-RNA role in different disease classes.

Some of the major players contributing to the global micro-RNA market comprises Access Pharmaceuticals, Agilent Technologies, Astrazeneca Pharmaceuticals LP, Benitec Biopharma Limited, Calando Pharmaceuticals, Inc., Covance, Inc., Eli Lilly and Co., F. Hoffman-La Roche AG, Illumina, Inc., Novartis International AG, Senesco Technologies, Inc., Sirnaomics, Inc., Tekmira Pharmaceuticals Corporation and Thermo Fisher Scientific, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
More reports on Pharmaceutical market: 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
Posted by at No comments:
Labels: , ,

Glyphosate Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Glyphosate Market
Glyphosate is the non-selective, broad spectrum herbicide. It is the useful to kill most of the perennial plants including sedges, grasses, broad-leaved weeds and woody plants. Glyphosate inhibits the enzymes involved in the synthesis of aromatic amino acids including tyrosine, tryptophan, and phenylalanine. Plants absorb it through the foliage and transfer it to the growing points of the plants thus it is effective against actively growing plants. 


The demand for Glyphosate is booming since last two decade. With the increase in planting area of transgenic crops and increase in bio-fuel projects in a number of countries worldwide, the demand for glyphosate has constantly increased since last many years. It is the largest selling agrochemical product across the world. 

Globally glyphosate is one of the most widely used herbicides in terms of volume. It has applications in horticulture, agriculture, viticulture, silviculture and garden maintenance. Moreover they are also use in many cities to clear the sidewalks, streets and railway tracks. The global demand for Glyphosate is expected to double in next five year as farmers switch to less labor intensive agricultural methods. In 2012 Asia Pacific dominated the glyphosate market, accounted for the largest share in terms of volume. 

The growth in the market was led by Asia Pacific and is expected to be the fastest growing regional market in Asia Pacific growing at a double digit compounded annual growth rate (CAGR). China is the major producer of glyphosate in the world. Presently the market is facing intense competition with several generic players mainly Chinese manufacturers operating in the market. 

The increase in pace of urbanization around the world has resulted into significant reduction of the rural labor force resulting into increase in demand for glyphosates. Continuous usage of glyphosate has resulted into the formation of some resistant variety of weeds.  Resistance from such problematic weeds was one of the major concerns for the glyphosate industry, affects the survival of economic crop plants.  Launch of genetically modified crops, glyphosate tolerant, and the introduction of innovative glyphosate formulations will continue to drive the demand for glyphosate in near future. 

Since 2011, the price of glyphosate has been growing high. While the upward trend of price of glyphosate will depend upon the introduction and implementation of environmental protection regulation. High profit margins and significant revenue growth has attracted several new players to the market after the patent expiry of original product in 2000.

Some of the key participants in the market includes Nufarm Limited, Syngenta AG, E. I. du Pont de Nemours and Company, Dow AgroSciences LLC,Monsanto Company, Shandong Weifang Rainbow Chemical, Zhejiang Wynca Chemical Group Co. Ltd., Anhui Huaxing Chemical Industry Co. Ltd., Nantong Jiangshan Agrochemical & Chemical Co. Ltd.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
More reports on Chemicals & Materials market: 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
Posted by at No comments:
Labels: , ,

Friday 23 August 2013

Pulmonary Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Pulmonary Drug Delivery Systems Market
The drug delivery method plays a crucial part in the success of any drug. Drugs with high efficacy and those which are easy to use are an instant success in most medical communities and even among patients. Pulmonary drug delivery is the inhalation of aerosol based drugs through a device called “Inhaler” and the drug aerosol is called an inhalable. 


There are several conventional inhalable drugs particularly for chronic conditions such as asthma, chronic obstructive pulmonary diseases (COPD) and congestion. Conventional methods used pulmonary drug delivery only for respiratory diseases. Today other chronic conditions such as diabetes also have inhaled insulin and provide greater patient comfort compared to insulin injections. Pulmonary drug delivery can be both oral and nasal.

The market for pulmonary drug delivery systems is predicted to grow with advancing technology such as automated pulmonary delivery testing systems. Increasing disease applications and innovative designs for devices will account for significant growth of this market. Faster delivery, greater absorbing surface area of tissue, and greater patient comfort are some of the drivers for pulmonary delivery of drugs. Even with these drivers, the market is not without its challenges. 

Research studies show that some people have lower absorption compared to others and thus the dosage has to be adjusted from one person to another making it difficult for physicians to standardize dosage for all people. Different formulations will also be provided a suitable platform for the delivery of other inhaled protein therapeutics besides insulin. Dry powder inhalers (DPIs) are still expected to have technical hurdles till the next few years.

Geographically the market can be focused world-wide and with increasing applications such as insulin, the market is projected to expand rapidly, particularly in Africa and Asia with large percentage of diabetic population. Currently North America and Europe lead the way in  the market respectively, yet the situation is expected to change in another five years. Insulin inhalers were recently approved in Europe and US, and the market is expected to present sizable opportunities in other regions around the world.
More reports on Pharmaceuticals market: 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. 

Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
Posted by at No comments:
Labels: , ,

Kidney Cancer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Kidney Cancer Drugs Market
Among the several diseases worldwide, cancer is majorly responsible for a high global mortality rate. The number of cancer patients is soaring and in 2012 it is projected that 1,638,910 new cases of cancer will be found, whereas 577,190 people are projected to die from cancer.


Of the several cancer types that exist, kidney cancer is projected to cause 12,484 deaths in 2012 and it is estimated that 59,588 new kidney cancer cases will emerge. Kidney cancer can be divided into two groups, i.e., renal pelvis cancer and renal parenchyma cancers.  The major segment of kidney cancer is renal parenchyma, which constitutes 92 percent of the total cancer cases. The projected new cases of this cancer are expected to reach 59,588 by 2012.

The rising cases of cancer per year are the major factor driving the kidney cancer drugs market. Expensive treatments through radiation and other equipments are the main restraints for this market. Technological advancement in future is expected to give rise to more efficient drugs and it may serve as the market opportunity in the future. 

The segmentation of the kidney cancer drugs market on the basis of technology used are as follows:
  • Surgical Treatment II-9
  • Multi-kinase Inhibitors II-10
  • Targeted Therapies II-10
  • mTOR Inhibitors II-10
  • Oral Targeted Therapies II-11
  • Pros and Cons of Targeted Therapies II-11
  • Injectable Targeted Therapy II-11
  • Monoclonal Antibodies II-11
  • Aldesleukin (Proleukin®) II-12
  • Immunomodulators II-12
  • Interferon alpha-2 (Roferon-A®) II-12
The major kidney cancer drugs available in market are as follows:
  • Sutent (Sunitinib) II-13
  • Sutent Vs. Interferon-alpha and IFN-alpha therapies II-1
  • Nexavar (Sorafenib) II-13
  • Votrient (Pazopanib) II-14
  • Avastin (Bevacizumab) II-1
  • Torisel (Temsirolimus) II-1
  • Afinitor (Everolimus) II-14
The geographies covered in this report are:
  • North America
  • Europe
  • Asia Pacific
  • RoW (Rest of the World)
Major players in the kidney cancer drug market are Bayer AG, Onyx Pharmaceuticals, Bristol-Myers Squibb Co., Inc., AVEO Pharmaceuticals, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Merck-Serono, Novartis AG, WILEX AG, and others.


This market research report analyzes important market segments, and major geographies. This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
Posted by at No comments:
Labels: , ,
Subscribe to: Posts (Atom)